MedTrace Logo

Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres

NCT03052049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-10-10

Study results available
· View outcomes & findings →

Summary

This is an open-labeled, non-randomized feasibility study to evaluate the safety of prostate artery embolization (PAE) for the treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH).

Conditions

  • Benign Prostatic Hyperplasia (BPH)

Interventions

DEVICE

Prostate Artery Embolization

The PAE procedure will be completed on all enrolled patients in Interventional Radiology includes a pelvic/prostate angiogram and embolization with Bead Block microspheres to slow/block blood flow to the prostate.

Sponsors & Collaborators

Principal Investigators

  • Riad Salem, MD · Northwestern University

  • Matthias Hofer, MD · Northwestern University

  • Bartley Thornburg, MD · Northwestern University

  • Kush Desai, MD · Northwestern University

  • Ahsun Riaz, MD · Northwestern University

  • Samdeep Mouli, MD · Northwestern University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-06
Primary Completion
2022-09-26
Completion
2022-09-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052049 on ClinicalTrials.gov